AM Bentley, Q Hamid, DS Robinson, E Schotman, Q Meng, B Assoufi, AB Kay and SR Durham
Department of Allergy and Clinical Immunology, National Heart and Lung Institute, London, United Kingdom.

We have tested the hypothesis that the beneficial effects of corticosteroids in asthma may result from reduction in the number of inflammatory cells infiltrating the bronchial mucosa with inhibition of cytokine gene expression. A randomized parallel group study was performed in 18 moderately severe asthmatic patients in whom an elective trial of corticosteroid treatment was indicated. Fiberoptic bronchoscopy was performed and bronchial biopsies taken from segmental carinae before and after 2 wk treatment with prednisolone (0.6 mg/kg/d) or matched placebo tablets. Immunohistology was performed on 6-microns cryostat sections using monoclonal antibodies. The number of cells expressing cytokine messenger RNA (mRNA) was assessed by in situ hybridization using S35-labeled riboprobes. When prednisolone- and placebo-treated groups were compared there was a decrease in airway methacholine responsiveness (p < 0.01) and an increase in FEV1 (p < 0.05) after prednisolone. This was accompanied by a reduction in CD3+ T lymphocytes (p < 0.05), "activated" EG2+ eosinophils (p < 0.02), and tryptase-only (mucosal-type) MCT cells (p < 0.02) but not MCTC (tryptase+chymase positive) cells in prednisolone-treated patients. In prednisolone-treated patients there was also a reduction in the number of cells expressing mRNA for interleukin-4 (IL-4, p < 0.01), and interleukin-5 (IL-5, p < 0.03) and an increase in cells expressing mRNA for interferon-gamma (IFN-gamma) (p < 0.01). These results support the view that corticosteroid treatment in asthma may act by modulation of cytokine expression with consequent inhibition of the local bronchial inflammatory infiltrate and tissue eosinophilia.

This article has been cited by other articles:

				S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056. [Abstract] [Full Text] [PDF]

				A. M. Slats, J. K. Sont, R. H.C.J. van Klink, E. H.D. Bel, and P. J. Sterk Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma. Chest, July 1, 2006; 130(1): 58 - 65. [Abstract] [Full Text] [PDF]

				E. CALCAGNI and I. ELENKOV Stress System Activity, Innate and T Helper Cytokines, and Susceptibility to Immune-Related Diseases Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 62 - 76. [Abstract] [Full Text] [PDF]

				S. Lajoie-Kadoch, P. Joubert, S. Letuve, A. J. Halayko, J. G. Martin, A. Soussi-Gounni, and Q. Hamid TNF-{alpha} and IFN-{gamma} inversely modulate expression of the IL-17E receptor in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1238 - L1246. [Abstract] [Full Text] [PDF]

				C. Bergeron and L.-P. Boulet Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, April 1, 2006; 129(4): 1068 - 1087. [Abstract] [Full Text] [PDF]

				P. Stock, O. Akbari, R. H. DeKruyff, and D. T. Umetsu Respiratory Tolerance Is Inhibited by the Administration of Corticosteroids J. Immunol., December 1, 2005; 175(11): 7380 - 7387. [Abstract] [Full Text] [PDF]

				S. Balzar, H. W. Chu, M. Strand, and S. Wenzel Relationship of Small Airway Chymase-Positive Mast Cells and Lung Function in Severe Asthma Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 431 - 439. [Abstract] [Full Text] [PDF]

				K. G. Tantisira, E. S. Hwang, B. A. Raby, E. S. Silverman, S. L. Lake, B. G. Richter, S. L. Peng, J. M. Drazen, L. H. Glimcher, and S. T. Weiss TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids PNAS, December 28, 2004; 101(52): 18099 - 18104. [Abstract] [Full Text] [PDF]

				P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]

				M. G. Belvisi Regulation of Inflammatory Cell Function by Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 207 - 214. [Abstract] [Full Text] [PDF]

				S O'Sullivan, L Cormican, C M Burke, and L W Poulter Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics Thorax, August 1, 2004; 59(8): 657 - 661. [Abstract] [Full Text] [PDF]

				R. E. Wiley, M. Cwiartka, D. Alvarez, D. C. Mackenzie, J. R. Johnson, S. Goncharova, L. Lundblad, and M. Jordana Transient Corticosteroid Treatment Permanently Amplifies the Th2 Response in a Murine Model of Asthma J. Immunol., April 15, 2004; 172(8): 4995 - 5005. [Abstract] [Full Text] [PDF]

				M. Stoeck, R. Riedel, G. Hochhaus, D. Hafner, J. M. Masso, B. Schmidt, A. Hatzelmann, D. Marx, and D. S. Bundschuh In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 249 - 258. [Abstract] [Full Text]

				C. E. Brightling, I. D. Pavord, P. T. Flood-Page, A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson Eosinophils in Asthma and Airway Hyperresponsiveness Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 131 - 133. [Full Text]

				Y. Cai, L. Bjermer, and T. S. Halstensen Bronchial Mast Cells Are the Dominating LTC4S-Expressing Cells in Aspirin-Tolerant Asthma Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 683 - 693. [Abstract] [Full Text] [PDF]

				V Brown, T J Warke, M D Shields, and M Ennis T cell cytokine profiles in childhood asthma Thorax, April 1, 2003; 58(4): 311 - 316. [Abstract] [Full Text] [PDF]

				P. T. Flood-Page, A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson Eosinophil's Role Remains Uncertain as Anti-Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 199 - 204. [Abstract] [Full Text] [PDF]

				N G Carroll, S Mutavdzic, and A L James Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma Thorax, August 1, 2002; 57(8): 677 - 682. [Abstract] [Full Text] [PDF]

				H. Shen, P. M. O'Byrne, R. Ellis, J. Wattie, C. Tang, and M. D. Inman The Effects of Intranasal Budesonide on Allergen-induced Production of Interleukin-5 and Eotaxin, Airways, Blood, and Bone Marrow Eosinophilia, and Eosinophil Progenitor Expansion in Sensitized Mice Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 146 - 153. [Abstract] [Full Text] [PDF]

				K. L. Hattotuwa, M. J. Gizycki, T. W. Ansari, P. K. Jeffery, and N. C. Barnes The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease: A Double-Blind, Placebo-controlled Biopsy Study Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1592 - 1596. [Abstract] [Full Text] [PDF]

				N.G. Carroll, S. Mutavdzic, and A.L. James Distribution and degranulation of airway mast cells in normal and asthmatic subjects Eur. Respir. J., May 1, 2002; 19(5): 879 - 885. [Abstract] [Full Text] [PDF]

				H. Hakonarson, E. Halapi, R. Whelan, J. Gulcher, K. Stefansson, and M. M. Grunstein Association Between IL-1beta /TNF-alpha -Induced Glucocorticoid-Sensitive Changes in Multiple Gene Expression and Altered Responsiveness in Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 761 - 771. [Abstract] [Full Text] [PDF]

				L. BENAYOUN, S. LETUVE, A. DRUILHE, J. BOCZKOWSKI, M.-C. DOMBRET, P. MECHIGHEL, J. MEGRET, G. LESECHE, M. AUBIER, and M. PRETOLANI Regulation of Peroxisome Proliferator-activated Receptor gamma Expression in Human Asthmatic Airways . Relationship with Proliferation, Apoptosis, and Airway Remodeling Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1487 - 1494. [Abstract] [Full Text] [PDF]

				S. J. WILSON, A. WALLIN, G. DELLA-CIOPPA, T. SANDSTROM, and S. T. HOLGATE Effects of Budesonide and Formoterol on NF-kappa B, Adhesion Molecules, and Cytokines in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1047 - 1052. [Abstract] [Full Text] [PDF]

				D. Little, S. Khanolkar-Young, A. Coulthart, S. Suneetha, and D. N. J. Lockwood Immunohistochemical Analysis of Cellular Infiltrate and Gamma Interferon, Interleukin-12, and Inducible Nitric Oxide Synthase Expression in Leprosy Type 1 (Reversal) Reactions before and during Prednisolone Treatment Infect. Immun., May 1, 2001; 69(5): 3413 - 3417. [Abstract] [Full Text] [PDF]

				J.C. Kips, K.G. Tournoy, and R.A. Pauwels New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Eur. Respir. J., March 1, 2001; 17(3): 499 - 506. [Abstract] [Full Text] [PDF]

				E. A. BECKY KELLY, W. W. BUSSE, and N. N. JARJOUR Inhaled Budesonide Decreases Airway Inflammatory Response to Allergen Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 883 - 890. [Abstract] [Full Text]

				K. MAGHNI, R. TAHA, W. AFIF, Q. HAMID, and J. G. MARTIN Dichotomy between Neurokinin Receptor Actions in Modulating Allergic Airway Responses in an Animal Model of Helper T Cell Type 2 Cytokine-associated Inflammation Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1068 - 1074. [Abstract] [Full Text]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				B. Brooks, D. M. Briggs, N. C. Eastmond, D. G. Fernig, and J. W. Coleman Presentation of IFN-{gamma} to Nitric Oxide-Producing Cells: A Novel Function for Mast Cells J. Immunol., January 15, 2000; 164(2): 573 - 579. [Abstract] [Full Text] [PDF]

				R. Chen, T. F. Burke, J. E. Cumberland, M. Brummet, L. A. Beck, V. Casolaro, and S. N. Georas Glucocorticoids Inhibit Calcium- and Calcineurin-Dependent Activation of the Human IL-4 Promoter J. Immunol., January 15, 2000; 164(2): 825 - 832. [Abstract] [Full Text] [PDF]

				L. HART, S. LIM, I. ADCOCK, P. J. BARNES, and K. FAN CHUNG Effects of Inhaled Corticosteroid Therapy on Expression and DNA-Binding Activity of Nuclear Factor kappa B in Asthma Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 224 - 231. [Abstract] [Full Text]

				R J Meijer, H A M Kerstjens, L R Arends, H F Kauffman, G H Koëter, and D S Postma Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma Thorax, October 1, 1999; 54(10): 894 - 899. [Abstract] [Full Text]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				J. E. Chin, C. A. Hatfield, G. E. Winterrowd, R. F. Krzesicki, K. L. Shull, S. F. Fidler, K. P. Kolbasa, J. R. Brashler, R. L. Griffin, W. E. Fleming, et al. Preclinical Evaluation of Anti-inflammatory Activities of the Novel Pyrrolopyrimidine PNU-142731A, a Potential Treatment for Asthma J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 188 - 195. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				A. Druilhe, B. Wallaert, A. Tsicopoulos, J.-R. L. e Silva, I. Tillie-Leblond, A.-B. Tonnel, and M. Pretolani Apoptosis, Proliferation, and Expression of Bcl-2, Fas, and Fas Ligand in Bronchial Biopsies from Asthmatics Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 747 - 757. [Abstract] [Full Text]

				H. Nakamura, K. J. Haley, T. Nakamura, A. D. Luster, and C. M. Lilly Differential regulation of eotaxin expression by TNF-alpha and PMA in human monocytic U-937 cells Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L601 - L610. [Abstract] [Full Text] [PDF]

				M Gaga, A M Bentley, M Humbert, J Barkans, F O'Brien, C G Wathen, A B Kay, and S R Durham Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis Thorax, August 1, 1998; 53(8): 685 - 691. [Abstract] [Full Text]